Dilution of Equity Value from the Exercise of Stock Acquisition Rights
First written in FY2018. 18 of 23 entries say "Materialised", first in FY2019-Q3. Latest entry: 2026-05-28.
Valuence Holdings moved to the "Worse" side of this theme in 2019, 2 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- 2026-05-28MitigatedShare Issuance and Disposal
「With respect to the fourth and sixth series of stock acquisition rights already issued by the company, following the retirement of eligible recipients, we acquired some of the remaining stock acquisition rights without consideration and held them as treasury stock acquisition rights in the company's name. As the company does not intend to exercise these treasury stock acquisition rights, they will be cancelled.」
The company cancelled 8 fourth-series stock acquisition rights and 50 sixth-series stock acquisition rights, reducing the total number of potential shares by 5,800. The potential dilution from exercising stock acquisition rights was partially reduced. - FY2026-H1MaterialisedAnnual report
「On 25 December 2025, the issuance of new shares as restricted stock compensation increased the total number of issued shares by 181,900, capital stock by ¥82.946 million and the capital reserve by ¥82.764 million.」
The issuance of 181,900 new shares as restricted stock compensation took place, resulting in actual potential dilution from the increase in the number of shares. - FY2025MaterialisedAnnual report
「1 September 2024 to 31 August 2025 (Note) 1 2,610 13,744,460 587 1,373,285 587 1,459,017」
The exercise of stock acquisition rights resulted in the issuance of 2,610 shares, and the conversion of potential shares into issued shares continued. In addition, 208,900 new shares were issued as restricted stock compensation. - FY2025-H1MaterialisedAnnual report
「On 20 December 2024, the issuance of new shares as restricted stock compensation increased the total number of issued shares by 208,900 and increased capital stock and the capital reserve by ¥77.293 million each.」
In addition to the issuance of 208,900 new shares as restricted stock compensation, 2,610 shares were added through the exercise of stock acquisition rights, resulting in an actual increase in the number of shares. - FY2024-Q1WorsenedAnnual report
「(3) Number of stock acquisition rights issued 290" (5) Class and number of shares underlying the stock acquisition rights Common shares 29,000 shares」
After the filing date, stock acquisition rights covering 29,000 shares were issued, adding a potential source of dilution from future exercise. - FY2023WorsenedAnnual report
「We will continue to consider using these schemes. However, if the stock acquisition rights are exercised or restricted stock is granted, the equity value per share of the Company may be diluted.」
In addition to the issuance of 52,400 restricted shares, the issuance of stock acquisition rights covering 29,000 shares and the issuance of 105,400 restricted shares were scheduled after the filing date, adding potential sources of dilution. - FY2023-Q2MaterialisedAnnual report
「Under a simplified share exchange in which our company became the wholly owning parent company and 株式会社米自動車 became the wholly owned subsidiary, the total number of issued shares increased by 34,800 shares and the capital surplus increased by ¥95.734 million.」
34,800 shares were issued in a share exchange with a US automobile company, resulting in an actual increase in the number of shares that diluted equity value. - FY2023-Q1MaterialisedAnnual report
「1 September 2022 to 30 November 2022 (Note) 2,120 13,337,740 274 1,146,609 274 1,136,607」
The total number of issued shares increased by 2,120 through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥274,000. - FY2022MaterialisedAnnual report
「Increase through the exercise of rights 9,450 shares」
During the fiscal year, 9,450 shares were issued through the exercise of stock acquisition rights, advancing the conversion of potential shares into issued shares and resulting in dilution. - FY2022-Q3MaterialisedAnnual report
「1 March 2022 to 31 May 2022 1,200 13,335,620 155 1,146,335 155 1,136,333」
Through the exercise of stock acquisition rights, the total number of issued shares increased by 1,200 during the third quarter accounting period, while capital stock and the capital reserve each increased by ¥155,000. - FY2022-Q2MaterialisedAnnual report
「Number of shares underlying the stock acquisition rights (shares) * 79,500」
The terms of the 5th Series Stock Acquisition Rights cover 79,500 underlying shares. The exercise period runs from 26 November 2023 to 24 November 2031. - FY2022-Q1MaterialisedAnnual report
「1 September 2021 to 30 November 2021 8,250 13,334,420 1,603 1,146,179 1,603 1,136,177」
The total number of issued shares increased by 8,250 through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥1.603 million. - FY2021MaterialisedAnnual report
「Increase from the exercise of stock acquisition rights: 143,010 shares」
During the fiscal year, 143,010 shares were issued through the exercise of stock acquisition rights, advancing the conversion of potential shares into issued shares. The 168,200 shares covered by the 4th Series Stock Acquisition Rights also remained unexercised. - FY2021-Q3MaterialisedAnnual report
「1 March 2021–31 May 2021 5,050 13,317,880 654 1,142,730 654 1,132,728」
The total number of shares issued increased by 5,050 through the exercise of share acquisition rights during the third-quarter period, while capital stock and the capital reserve each increased by ¥654 thousand. - FY2021-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares issued increased by 98,880 through the exercise of share acquisition rights during the cumulative second-quarter period, advancing the conversion of potential shares into shares. - FY2021-Q1WorsenedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares issued increased by 30,790 through the exercise of share acquisition rights in the first quarter, advancing the conversion of potential shares into shares, resulting in dilution. - FY2020MaterialisedAnnual report
「Increase through the exercise of share acquisition rights 435,300 shares」
The total number of shares issued increased by 435,300 through the exercise of share acquisition rights during the consolidated fiscal year, advancing the conversion of potential shares into shares, resulting in dilution. - FY2020-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares issued increased by 27,540 through the exercise of share acquisition rights in the third quarter, advancing the conversion of potential shares into issued shares. - FY2020-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares issued increased by 187,600 through the exercise of share acquisition rights during the cumulative second-quarter period, advancing the conversion of potential shares into shares, resulting in dilution. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares issued increased by 185,450 through the exercise of share acquisition rights in the first quarter, advancing the conversion of potential shares into issued shares. - FY2019MaterialisedAnnual report
「As of the date of submission of this document, the number of potential shares arising from these share acquisition rights was 683,650, equivalent to 5.36% of the total number of shares issued.」
The total number of shares issued continued to increase through the exercise of share acquisition rights, rising by 303,420 shares during the consolidated fiscal year. The number of potential shares was 683,650, equivalent to 5.36% of the total number of shares issued. - FY2019-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the cumulative third-quarter period, the total number of shares issued increased by 218,060 through the exercise of share acquisition rights, resulting in the conversion of potential shares into issued shares. - FY2018First statedAnnual report
「As of the date of submission of this document, the number of potential shares arising from these share acquisition rights was 660,375, equivalent to 10.88% of the total number of shares issued.」
The potential for dilution of share value through the exercise of share acquisition rights was quantified for the first time at 660,375 potential shares, equivalent to 10.88% of the total number of shares issued.